Oaktree Acquisition Corp. III Life Sciences (OACC)

Oaktree Acquisition Corp. III Life Sciences (OACC) is a financial services company (shell companies) based in the United States. The share price is $10.70, up 0.00% on the day, which values the company at $141.79M. Price as of 17 Nov 2026, 17:41 UTC, from Yahoo Finance.

Key facts

Share price
$10.70+0.00% today
Market value
$141.79M
P/E ratio
59.4×last 12 months
Sector
Financial Services

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Oaktree Acquisition Corp. III Life Sciences in more detail

OACC trades at 59.4× its last twelve months' earnings.

In its favour: More cash than debt. Worth checking: Profit is not turning into cash.

1 of the superinvestors tracked here hold OACC, including Louis Bacon (0.2% of the portfolio).

Superinvestors holding OACC

1 of the investors tracked here report a position in their latest 13F filing.

Oaktree Acquisition Corp. III Life Sciences (OACC): questions and answers

What is OACC's P/E ratio?

Oaktree Acquisition Corp. III Life Sciences trades at 59.4× its last twelve months' earnings.

What is Oaktree Acquisition Corp. III Life Sciences's market cap?

Oaktree Acquisition Corp. III Life Sciences is valued at $141.79M at a share price of $10.70.

Does OACC pay a dividend?

Oaktree Acquisition Corp. III Life Sciences does not currently pay a regular dividend.

Which famous investors own OACC?

In their latest quarterly filings, Louis Bacon (0.2% of the portfolio) hold OACC. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Oaktree Acquisition Corp. III Life Sciences (OACC) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/OACC

Underlying data: Yahoo Finance; company filings with the SEC.